Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Equity (2016 - 2025)

Abeona Therapeutics has reported Return on Equity over the past 15 years, most recently at 0.47% for Q4 2025.

  • Quarterly results put Return on Equity at 0.47% for Q4 2025, up 153.0% from a year ago — trailing twelve months through Dec 2025 was 0.47% (up 153.0% YoY), and the annual figure for FY2025 was 0.7%, up 287.0%.
  • Return on Equity for Q4 2025 was 0.47% at Abeona Therapeutics, down from 0.53% in the prior quarter.
  • Over the last five years, Return on Equity for ABEO hit a ceiling of 0.63% in Q2 2025 and a floor of 17.06% in Q1 2024.
  • Median Return on Equity over the past 5 years was 1.38% (2021), compared with a mean of 2.56%.
  • Biggest five-year swings in Return on Equity: tumbled -1517bps in 2024 and later skyrocketed 1582bps in 2025.
  • Abeona Therapeutics' Return on Equity stood at 1.53% in 2021, then crashed by -72bps to 2.64% in 2022, then grew by 2bps to 2.58% in 2023, then skyrocketed by 59bps to 1.06% in 2024, then soared by 145bps to 0.47% in 2025.
  • The last three reported values for Return on Equity were 0.47% (Q4 2025), 0.53% (Q3 2025), and 0.63% (Q2 2025) per Business Quant data.